Stereotaxis Inc. Company Profile
NYSE: STXSHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Stereotaxis at a glance
Stereotaxis Inc. (NYSE: STXS) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company in the Health Care sector headquartered in Saint Louis, MO. Stereotaxis is led by Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. and employs about 131 people. At a market capitalization of $111.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001289340, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Stereotaxis do?
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Business description based on the company's public filings.
Company information
- Legal name
- Stereotaxis Inc.
- Ticker
- NYSE: STXS
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
- Employees
- 131
- Headquarters
- 710 North Tucker Boulevard, Saint Louis, MO, United States
- Phone
- 314 678 6100
- Website
- stereotaxis.com
- Market cap
- $111.22M
- SEC CIK
- 0001289340
Companies similar to Stereotaxis
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VANIVivani Medical Inc. | 1.25 | +1.63% | $112.75M | vs STXS |
| HYPRHyperfine Inc. Class A | 0.9307 | -1.00% | $98.70M | vs STXS |
| ECORelectroCore Inc. | 9.66 | +1.58% | $87.09M | vs STXS |
| NRXSNeuraxis Inc. | 6.93 | +2.36% | $87.03M | vs STXS |
| OMOutset Medical Inc. | 4.05 | -0.98% | $76.13M | vs STXS |
| HSDTSolana Company Class A | 2.39 | +0.42% | $155.60M | vs STXS |
| POCIPrecision Optics Corporation Inc. | 4.58 | -1.82% | $50.26M | vs STXS |
| QTIQT Imaging Holdings Inc. | 2.68 | +3.08% | $39.23M | vs STXS |